Filing Details
- Accession Number:
- 0001179110-11-003254
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-02-23 17:13:39
- Reporting Period:
- 2011-02-23
- Filing Date:
- 2011-02-23
- Accepted Time:
- 2011-02-23 17:13:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
884629 | Watson Pharmaceuticals Inc | WPI | Pharmaceutical Preparations (2834) | 953872914 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1236488 | J Michel Feldman | 626 Homewood Avenue #107 Highland Park IL 60035 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.0033 | Acquisiton | 2011-02-23 | 30,000 | $48.48 | 40,000 | No | 4 | M | Direct | |
Common Stock, Par Value $0.0033 | Disposition | 2011-02-23 | 30,000 | $54.98 | 10,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.0033 | Non-Qualified Options to Purchase Common Stock | Disposition | 2011-02-23 | 30,000 | $0.00 | 30,000 | $48.48 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2004-05-07 | 2011-05-07 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock, Par Value $0.0033 | 1,000 | Indirect | by spouse |
Footnotes
- Includes shares of restricted stock issued pursuant to the Third Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc.